Advertisement
ABOS 外匯新聞
Acumen Pharma Partners Lonza To Advance Sabirnetug For Alzheimer's Disease Treatment
Biopharmaceutical company Acumen Pharmaceuticals, Inc. (ABOS) on Thursday signed a collaboration agreement with Lonza, a global partner to the pharmaceutical, biotech and nutraceutical markets.
RTTNews
|
518天前
